Related Experiment Video
Updated: Aug 4, 2025
Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
Published on: September 15, 2021
Promises and challenges of cardiac organoids
Jingxian Li1, Jingsi Yang1, Dandan Zhao1
1Department of Cardiovascular Surgery of the First Affiliated Hospital & Institute for Cardiovascular Science, Collaborative Innovation Center of Hematology, State Key Laboratory of Radiation Medicine and Protection, Suzhou Medical College, Soochow University, Suzhou, 215000, China.
Abstract:
Cardiovascular diseases are currently the main cause of death. The study of the pathogenesis and treatment of these diseases is still a major challenge. Traditional 2D cultured cells and animal models have certain limitations. Heart organoids as models can simulate the structure and function of the body, providing a new research strategy. This paper mainly discusses the development of organoids and their application in the study of the cardiac developmental process, drug screening and treatment of genetic and non-genetic diseases, concluding with their strengths and weaknesses.
Insights
Heart organoids offer a novel strategy for studying cardiovascular diseases, overcoming limitations of traditional models. These advanced models aid in understanding heart development, screening drugs, and treating cardiac conditions.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Developmental Biology
Background:
- Cardiovascular diseases represent a leading global cause of mortality.
- Investigating cardiovascular disease pathogenesis and treatment remains a significant scientific challenge.
- Conventional 2D cell cultures and animal models present inherent limitations in accurately recapitulating human cardiac physiology.
Purpose of the Study:
- To explore the development and applications of heart organoids as advanced research models.
- To highlight the utility of heart organoids in understanding cardiac development and disease.
- To evaluate the potential of heart organoids for drug screening and therapeutic strategies in cardiovascular conditions.
Main Methods:
- Review of current literature on heart organoid development and technological advancements.
- Analysis of studies utilizing heart organoids for modeling cardiac developmental processes.
- Examination of research employing heart organoids for drug efficacy and toxicity screening.
Main Results:
- Heart organoids can effectively mimic the structural and functional complexity of the human heart.
- Organoid models facilitate the study of cardiac development and the mechanisms underlying genetic and non-genetic cardiovascular diseases.
- Applications in drug screening show promise for personalized medicine approaches in cardiology.
Conclusions:
- Heart organoids represent a significant advancement over traditional models for cardiovascular research.
- Their ability to simulate in vivo conditions provides a powerful platform for disease modeling and therapeutic development.
- Further research is warranted to fully elucidate the potential and limitations of heart organoids in clinical applications.
More Related Videos
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
09:35Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
Published on: June 16, 2020